Stock Events

Coloplast AS 

$11.09
15
-$0.11-0.98% Today

Statistics

Day High
11.35
Day Low
11.09
52W High
14.77
52W Low
9.9
Volume
29,058
Avg. Volume
77,263
Mkt Cap
24.1B
P/E Ratio
0
Dividend Yield
2.73%
Dividend
0.3

Upcoming

Dividends

2.73%Dividend Yield
Dec 23
$0.23
May 23
$0.07
Dec 22
$0.21
May 22
$0.07
Dec 21
$0.21

Earnings

9FebExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
0
0.03
0.06
0.1
Expected EPS
0.0874
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLPBY. It's not an investment recommendation.

About

Medical Specialties
Health Technology
Manufacturing
Surgical and Medical Instrument Manufacturing
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Show more...
CEO
Kristian Villumsen
Employees
14000
Country
US
ISIN
US19624Y2000
WKN
000A2P4CC

Listings